Insider Transactions in Q3 2021 at Bausch Health Companies Inc. (BHC)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,234
+0.39%
|
$33,318
$27.85 P/Share
|
|
Sep 30
2021
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,099
+9.35%
|
$29,673
$27.85 P/Share
|
|
Sep 30
2021
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,099
+9.25%
|
$29,673
$27.85 P/Share
|
|
Sep 30
2021
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,099
+1.29%
|
$29,673
$27.85 P/Share
|
|
Sep 30
2021
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,368
+1.08%
|
$36,936
$27.85 P/Share
|
|
Sep 30
2021
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
246
+0.25%
|
$6,642
$27.85 P/Share
|
|
Sep 14
2021
|
Joseph C Papa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,010
-0.48%
|
$140,280
$28.66 P/Share
|
|
Sep 13
2021
|
Joseph C Papa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,549
-0.34%
|
$102,921
$29.19 P/Share
|
|
Sep 01
2021
|
Thomas Appio Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,260
+21.96%
|
-
|
|
Sep 01
2021
|
Robert Spurr President, U.S. Businesses |
BUY
Grant, award, or other acquisition
|
Direct |
9,026
+11.86%
|
-
|
|
Aug 27
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
5,017
-3.01%
|
$140,476
$28.95 P/Share
|
|
Aug 27
2021
|
Robert Spurr President, U.S. Businesses |
SELL
Payment of exercise price or tax liability
|
Direct |
1,278
-2.15%
|
$35,784
$28.95 P/Share
|
|
Aug 05
2021
|
Andrew C. Von Eschenbach Director |
BUY
Open market or private purchase
|
Direct |
1,400
+3.5%
|
$35,000
$25.94 P/Share
|
|
Aug 04
2021
|
Richard U De Schutter Director |
BUY
Open market or private purchase
|
Direct |
10,000
+3.06%
|
$250,000
$25.01 P/Share
|